0001348324-16-000168.txt : 20160311 0001348324-16-000168.hdr.sgml : 20160311 20160311162851 ACCESSION NUMBER: 0001348324-16-000168 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160311 FILED AS OF DATE: 20160311 DATE AS OF CHANGE: 20160311 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LDR HOLDING CORP CENTRAL INDEX KEY: 0001348324 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 203933262 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 13785 RESEARCH BOULEVARD STREET 2: SUITE 200 CITY: AUSTIN STATE: TX ZIP: 78750 BUSINESS PHONE: 512-344-3333 MAIL ADDRESS: STREET 1: 13785 RESEARCH BOULEVARD STREET 2: SUITE 200 CITY: AUSTIN STATE: TX ZIP: 78750 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ross G. Joseph CENTRAL INDEX KEY: 0001586612 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36095 FILM NUMBER: 161501106 MAIL ADDRESS: STREET 1: C/O LDR HOLDING CORPORATION STREET 2: 13785 RESEARCH BLVD STE 200 CITY: AUSTIN STATE: TX ZIP: 78750 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2016-03-11 0 0001348324 LDR HOLDING CORP LDRH 0001586612 Ross G. Joseph 13785 RESEARCH BLVD., SUITE 200 AUSTIN TX 78750 0 1 0 0 Exec VP Global Marketing Common Stock 2016-03-11 4 M 0 2288.0 3.105 A 7520 D Common Stock 2016-03-11 4 M 0 10093.0 5.94 A 17613 D Common Stock 2016-03-11 4 S 0 17613.0 23.0731 D 0 D Incentive Stock Option (right to buy) 3.105 2016-03-11 4 M 0 2288.0 0.0 D 2012-02-01 2020-11-19 Common Stock 2288 0 D Incentive Stock Option (right to buy) 5.94 2016-03-11 4 M 0 10093.0 0.0 D 2013-07-10 2022-07-10 Common Stock 10093 1176 D Includes 394 and 306 ESPP shares acquired under the LDR Holding Corporation Amended and Restated 2013 Employee Stock Purchase Plan on May 31, 2015 and November 30, 2015 respectively. Also includes 842 RSU shares acquired on 1/1/16, 1,263 RSU shares acquired on 1/16/16, and 2,427 Performance RSU shares acquired on 2/15/16. The price indicated is the weighted average sale price for the shares sold. The individual sale price for the shares indicated range from $22.87 to $23.24. The reporting person undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, further information regarding the number of shares sold at each separate price such shares were sold. ISO becomes exercisable in combination with NQSO granted on the same date wherein the shares vest in forty-eight equal monthly installments from the vesting commencement date of January 1, 2012. ISO becomes exercisable in combination with NQSO granted on the same date wherein 25% of the shares granted become exercisable upon one year from the vesting commencement date of July 10, 2012, then in thirty-six equal monthly installments thereafter. By: Scott E. Way For: Ross G. Joseph 2016-03-11